Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.34 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.34 |
| ▸ | FAAH | O00519 | 1/20 | 0.34 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.33 |
| ▸ | OXER1 | Q8TDS5 | 2/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.33 |
| ▸ | RELA | Q04206 | 1/20 | 0.33 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.32 |
| ▸ | TET3 | O43151 | 1/20 | 0.32 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9565306 | 1.00 | MAPT (0.39) | MAPTABCC4SMN1; SMN2USP2LMNA | |
| SCHEMBL9565295 | 0.96 | MAPT (0.44) | MAPTABCC4SMN1; SMN2USP2LMNA | |
| SCHEMBL9565299 | 0.96 | MAPT (0.44) | MAPTABCC4SMN1; SMN2USP2LMNA | |
| SCHEMBL9577740 | 0.94 | MAPT (0.47) | MAPTABCC4SMN1; SMN2USP2LMNA | |
| SCHEMBL9577718 | 0.94 | MAPT (0.47) | MAPTABCC4SMN1; SMN2USP2LMNA | |
| SCHEMBL9565334 | 0.94 | MAPT (0.47) | MAPTABCC4SMN1; SMN2USP2LMNA | |
| SCHEMBL9577850 | 0.94 | MAPT (0.47) | MAPTABCC4SMN1; SMN2USP2LMNA | |
| SCHEMBL9577972 | 0.94 | MAPT (0.47) | MAPTABCC4SMN1; SMN2USP2LMNA | |
| SCHEMBL9565301 | 0.94 | MAPT (0.47) | MAPTABCC4SMN1; SMN2USP2LMNA | |
| SCHEMBL9577926 | 0.94 | MAPT (0.47) | MAPTABCC4SMN1; SMN2USP2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0568307-A1 | Cosmetic composition containing alpha hydroxy carboxylic acids as preservatives | UNILEVER PLC (GB) | 1993-11-03 | — | — | EP | claimed |
| US-5108751-A | COSMETIC COMPOSITION COMPRISING 2-HYDROXYALKENOIC ACIDS OR A MIXTURE THEREOF | CHESEBROUGH-POND'S USA CO., DIVISION OF CONOPCO, INC. (US) | 1992-04-28 | — | — | US | claimed |
| EP-0442708-A2 | Cosmetic composition | UNILEVER PLC (GB) | 1991-08-21 | — | — | EP | claimed |
| US-12082582-B2 | Synergistic preservative compositions, process for preparing the same and method of use thereof | ISP INVESTMENTS LLC (US) | 2024-09-10 | — | — | US | disclosed |
| CN-113301802-B | Synergistic preservative compositions, methods of making and methods of use thereof | ISP投资有限公司 | 2023-08-25 | — | — | CN | disclosed |
| CN-107613767-B | Synergistic preservative composition | ISP投资有限公司 | 2022-06-21 | — | — | CN | disclosed |
| US-20220030862-A1 | SYNERGISTIC PRESERVATIVE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC (US) | 2022-02-03 | — | — | US | disclosed |
| EP-3886582-A1 | SYNERGISTIC PRESERVATIVE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP Investments LLC (US) | 2021-10-06 | — | — | EP | disclosed |
| CN-113301802-A | Synergistic preservative compositions, methods of making and methods of using the same | ISP投资有限公司 | 2021-08-24 | — | — | CN | disclosed |
| WO-2020113211-A1 | SYNERGISTIC PRESERVATIVE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC (US) | 2020-06-04 | — | — | WO | disclosed |
| US-20180092357-A1 | SYNERGISTIC PRESERVATIVE COMPOSITIONS | ISP INVESTMENTS LLC (US) | 2018-04-05 | — | — | US | disclosed |
| EP-3288380-A1 | SYNERGISTIC PRESERVATIVE COMPOSITIONS | ISP Investments LLC (US) | 2018-03-07 | — | — | EP | disclosed |
| WO-2016164555-A1 | SYNERGISTIC PRESERVATIVE COMPOSITIONS | ISP INVESTMENTS INC. (US) | 2016-10-13 | — | — | WO | disclosed |
| EP-0568307-A1 | Cosmetic composition containing alpha hydroxy carboxylic acids as preservatives | UNILEVER PLC (GB) | 1993-11-03 | — | — | EP | disclosed |
| US-5227503-A | 2-Hydroxyalkenoic acids | CHESEBROUGH POND'S USA CO., DIVISION OF CONOPCO, INC. (US) | 1993-07-13 | — | — | US | disclosed |
| US-5108751-A | COSMETIC COMPOSITION COMPRISING 2-HYDROXYALKENOIC ACIDS OR A MIXTURE THEREOF | CHESEBROUGH-POND'S USA CO., DIVISION OF CONOPCO, INC. (US) | 1992-04-28 | — | — | US | disclosed |
| EP-0442708-A2 | Cosmetic composition | UNILEVER PLC (GB) | 1991-08-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12082582-B2 | Synergistic preservative compositions, process for preparing the same and method of use thereof | HPD, EBP, TET1 | MAPT 1525/4885ABCC4 4732/4885SMN1; SMN2 3656/4885 |
| US-20180092357-A1 | SYNERGISTIC PRESERVATIVE COMPOSITIONS | PIEZO1, CASP1, PRNP | MAPT 2190/4885ABCC4 3330/4885SMN1; SMN2 1139/4885 |
| US-20220030862-A1 | SYNERGISTIC PRESERVATIVE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | HPD, EBP, TET1 | MAPT 1525/4885ABCC4 4732/4885SMN1; SMN2 3656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.